Location: Del Mar, CA
CIK: 0001993440 · Show all filings
Period: Q1 2026 (← Previous) (Next →)
Filing Date: May 15, 2026
Total Value: $895M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS CORP DEL | 104,726 | $62.1M | 6.9% | $392.94 | +22.3% | COM | 91307C102 |
| ABVX | ABIVAX SA | 465,869 | $51.87M | 5.8% | $99.29 | — | SPONSORED ADS | 00370M103 |
| BBIO | BRIDGEBIO PHARMA INC | 695,718 | $51.66M | 5.8% | $36.28 | +105.3% | COM | 10806X102 |
| XENE | XENON PHARMACEUTICALS INC | 786,844 | $45.75M | 5.1% | $37.92 | +10.7% | COM | 98420N105 |
| RVMD | REVOLUTION MEDICINES INC | 468,376 | $45.55M | 5.1% | $45.05 | +128.7% | COM | 76155X100 |
| APGE | APOGEE THERAPEUTICS INC | 513,770 | $43.24M | 4.8% | $49.95 | +44.6% | COM | 03770N101 |
| INSM | INSMED INC | 248,475 | $40.63M | 4.5% | $48.11 | +230.6% | COM PAR $.01 | 457669307 |
| NUVL | NUVALENT INC | 370,344 | $37.94M | 4.2% | $71.10 | +45.8% | COM | 670703107 |
| MIRM | MIRUM PHARMACEUTICALS INC | 400,464 | $36.99M | 4.1% | $33.08 | +191.9% | COM | 604749101 |
| COGT | COGENT BIOSCIENCES INC | 947,339 | $36.46M | 4.1% | $29.31 | +27.5% | COM | 19240Q201 |
| ROIV | ROIVANT SCIENCES LTD | 1,190,118 | $32.97M | 3.7% | $13.79 | +75.3% | SHS | G76279101 |
| AXSM | AXSOME THERAPEUTICS INC. | 188,772 | $31.91M | 3.6% | $94.05 | +91.7% | COM | 05464T104 |
| IDYA | IDEAYA BIOSCIENCES INC | 873,838 | $29.12M | 3.3% | $32.22 | +5.1% | COM | 45166A102 |
| ORIC | ORIC PHARMACEUTICALS INC | 2,017,284 | $25.56M | 2.9% | $10.42 | +3.4% | COM | 68622P109 |
| ELVN | ENLIVEN THERAPEUTICS INC | 623,839 | $24.45M | 2.7% | $25.60 | 0.0% | COM | 29337E102 |
| CELC | CELCUITY INC | 210,578 | $24.04M | 2.7% | $107.47 | 0.0% | COM | 15102K100 |
| SRRK | SCHOLAR ROCK HLDG CORP | 446,390 | $21.94M | 2.5% | $37.51 | +21.2% | COM | 80706P103 |
| KYMR | KYMERA THERAPEUTICS INC | 254,672 | $21.21M | 2.4% | $51.25 | +51.4% | COM | 501575104 |
| CYTK | CYTOKINETICS INC | 283,700 | $18.7M | 2.1% | $45.77 | +40.8% | COM NEW | 23282W605 |
| DNTH | DIANTHUS THERAPEUTICS INC | 220,921 | $18.54M | 2.1% | $47.58 | 0.0% | COM | 252828108 |
| PVLA | PALVELLA THERAPEUTICS INC NE | 148,093 | $18.46M | 2.1% | $91.38 | 0.0% | COM | 697947109 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 558,336 | $17.87M | 2.0% | $23.08 | +46.2% | ORDINARY SHARES | N62509109 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 911,337 | $17.83M | 2.0% | $28.25 | +9.2% | COM | 92790C104 |
| ASND | ASCENDIS PHARMA A/S | 76,300 | $17.45M | 1.9% | $144.94 | — | SPONSORED ADR | 04351P101 |
| FULC | FULCRUM THERAPEUTICS INC | 2,256,109 | $17.3M | 1.9% | $10.21 | +1.6% | COM | 359616109 |
| TERN | TERNS PHARMACEUTICALS INC | 326,694 | $17.22M | 1.9% | $23.11 | +62.1% | COM | 880881107 |
| VERA | VERA THERAPEUTICS INC | 422,023 | $16.98M | 1.9% | $35.71 | +25.9% | CL A | 92337R101 |
| NTRA | NATERA INC | 81,077 | $16.21M | 1.8% | $128.20 | +76.2% | COM | 632307104 |
| ERAS | ERASCA INC | 867,639 | $14.04M | 1.6% | $10.02 | 0.0% | COM | 29479A108 |
| PRAX | PRAXIS PRECISION MEDICINES I | 42,441 | $13.67M | 1.5% | $206.03 | +51.3% | COM NEW | 74006W207 |
| OLMA | OLEMA PHARMACEUTICALS INC | 768,662 | $11.46M | 1.3% | $19.30 | +31.9% | COM | 68062P106 |
| QURE | UNIQURE NV | 615,489 | $10.06M | 1.1% | $31.41 | -25.0% | SHS | N90064101 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 315,563 | $5.882M | 0.7% | $46.07 | -65.2% | CLASS A ORD | 61559X104 |